| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 07/04/2017 | 21h23 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 27/02/2017 | 21h09 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 27/02/2017 | 16h30 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 21/02/2017 | 17h19 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 22h54 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 22h51 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 22h48 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 22h46 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 22h44 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 22h41 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 22h40 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 22h38 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 22h37 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 22h14 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 20h19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 20h19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 20h19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 20h18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 20h18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 20h18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 20h17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 20h17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 20h17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 20h16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 20h16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 20h15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 20h15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 20h15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 15h42 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 16/02/2017 | 15h15 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |